Literature DB >> 22752913

Nucleotide-binding oligomerization domain 2 (Nod2) is dispensable for the innate immune responses of macrophages against Yersinia enterocolitica.

Yu-Jin Jeong1, Chang-Hwan Kim, Eun-Jung Song, Min-Jung Kang, Jee-Cheon Kim, Sang-Muk Oh, Kyung-Bok Lee, Jong-Hwan Park.   

Abstract

Nucleotide-binding oligomerization domain 2 (Nod2) is a cytosolic sensor for muramyl dipeptide, a component of bacterial peptidoglycan. In this study, we have examined whether Nod2 mediates the immune response of macrophages against Yersinia enterocolitica. Bone-marrow-derived macrophages (BMDMs) were isolated from WT and Nod2-deficient mice and were infected with various strains of Y. enterocolitica. ELISA showed that the production of IL-6 and TNF-α in BMDMs infected with Y. enterocolitica was not affected by the Nod2 deficiency. iNOS mRNA expression was induced in both WT and Nod2-deficienct BMDMs in response to Y. enterocolitica, beginning 2 h after infection. Nitric oxide (NO) production by Y. enterocolitica did not differ between WT and Nod2-deficient BMDMs. Western blot analysis revealed that Y. enterocolitica induces activation of NF-κB, p38, and ERK MAPK through a Nod2-independent pathway. Neither LDH release by Y. enterocolitica nor the phagocytic activity of the macrophages was altered by Nod2 deficiency. An in vivo experiment showed that bacterial clearance ability and production of IL-6 and KC in serum were comparable in WT and Nod2-deficient mice infected with Y. enterocolitica. These findings suggest that Nod2 may not be critical for initiating the innate immune response of macrophages against Yersinia infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752913     DOI: 10.1007/s12275-012-1534-6

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  39 in total

1.  Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium.

Authors:  Ward M Richardson; Chhinder P Sodhi; Anthony Russo; Richard H Siggers; Amin Afrazi; Steven C Gribar; Matthew D Neal; Shipan Dai; Thomas Prindle; Maria Branca; Congrong Ma; John Ozolek; David J Hackam
Journal:  Gastroenterology       Date:  2010-05-24       Impact factor: 22.682

2.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

3.  NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens.

Authors:  Vinita S Chauhan; David G Sterka; Samantha R Furr; Amy B Young; Ian Marriott
Journal:  Glia       Date:  2009-03       Impact factor: 7.452

Review 4.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.

Authors:  Sanjeev Mariathasan; Denise M Monack
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

5.  Synergistic enhancement of Toll-like receptor responses by NOD1 activation.

Authors:  David A van Heel; Subrata Ghosh; Matt Butler; Karen Hunt; Brian Michael J Foxwell; Dominique Mengin-Lecreulx; Raymond J Playford
Journal:  Eur J Immunol       Date:  2005-08       Impact factor: 5.532

6.  Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.

Authors:  Shin Maeda; Li-Chung Hsu; Hongjun Liu; Laurie A Bankston; Mitsutoshi Iimura; Martin F Kagnoff; Lars Eckmann; Michael Karin
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

7.  Cross-tolerization between Nod1 and Nod2 signaling results in reduced refractoriness to bacterial infection in Nod2-deficient macrophages.

Authors:  Yun-Gi Kim; Jong-Hwan Park; Stephanie Daignault; Koichi Fukase; Gabriel Núñez
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.

Authors:  Mizuho Hasegawa; Yukari Fujimoto; Peter C Lucas; Hiroyasu Nakano; Koichi Fukase; Gabriel Núñez; Naohiro Inohara
Journal:  EMBO J       Date:  2007-12-13       Impact factor: 11.598

Review 9.  Plague: past, present, and future.

Authors:  Nils Chr Stenseth; Bakyt B Atshabar; Mike Begon; Steven R Belmain; Eric Bertherat; Elisabeth Carniel; Kenneth L Gage; Herwig Leirs; Lila Rahalison
Journal:  PLoS Med       Date:  2008-01-15       Impact factor: 11.069

10.  Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.

Authors:  A Celada; P W Gray; E Rinderknecht; R D Schreiber
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  4 in total

1.  NOD2 is dispensable for ATG16L1 deficiency-mediated resistance to urinary tract infection.

Authors:  Caihong Wang; Xuejun Yuan; Emily Ma; Graziella R Mendonsa; Theo S Plantinga; Lambertus A Kiemeney; Sita H Vermeulen; Indira U Mysorekar
Journal:  Autophagy       Date:  2013-12-18       Impact factor: 16.016

2.  LRRK2 and RIPK2 variants in the NOD 2-mediated signaling pathway are associated with susceptibility to Mycobacterium leprae in Indian populations.

Authors:  Patrick Marcinek; Aditya Nath Jha; Vidyagouri Shinde; Arun Sundaramoorthy; Raja Rajkumar; Naveen Chandra Suryadevara; Sanjeev Kumar Neela; Hoang van Tong; Vellingiri Balachander; Vijaya Lakshmi Valluri; Kumarasamy Thangaraj; Thirumalaisamy P Velavan
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

Review 3.  Nod2: The intestinal gate keeper.

Authors:  Ziad Al Nabhani; Gilles Dietrich; Jean-Pierre Hugot; Frederick Barreau
Journal:  PLoS Pathog       Date:  2017-03-02       Impact factor: 6.823

4.  NOD2/RICK-dependent β-defensin 2 regulation is protective for nontypeable Haemophilus influenzae-induced middle ear infection.

Authors:  Jeong-Im Woo; Sejo Oh; Paul Webster; Yoo Jin Lee; David J Lim; Sung K Moon
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.